Zeolite‐based hemostatic agents are considered as an outstanding material to achieve rapid and definitive hemostasis in pre‐hospital management. However, developing a safer zeolitic hemostat that avoids the potential thrombotic risk caused by tiny zeolite residue in bleeding wounds remains a critical challenge. In this research, we employ an in situ biosynthesis process to fabricate a sandwich‐like structured bacterial cellulose/zeolite (BC/zeolite) hybrid hemostat. Zeolite particles were firmly bonded into the BC membranes with <1% leaching after 24 soaking. This hemostat displays effective hemostatic performance after calcium ion‐exchange process. The BC/zeolite‐Ca hemostat can significantly decrease in vitro blood clotting time from 7.5 ± 0.3 min to 2.2 ± 0.3 min. This work achieves a low‐cost, eco‐friendly, and low‐risk approach through in situ biosynthesis in the preparation of BC‐ and zeolite‐based hybrid for pre‐hospital hemostasis applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.